Emmaus Medical, Inc. is a biopharmaceutical company located in Torrance, CA (Los Angeles County) and
is engaged in the discovery, development and commercialization of innovative treatments and therapies
primarily for rare and orphan diseases. We are initially focusing our product development efforts in Sickle
Cell Disease, an inherited genetic disorder. Our lead product, Endari, is an oral pharmaceutical grade Lglutamine treatment that demonstrated positive clinical results in our completed Phase III clinical trial and
is approved for use in sickle cell anemia and sickle ß0-thalassemia.